168 related articles for article (PubMed ID: 30735894)
1. Macrophage cell tracking PET imaging using mesoporous silica nanoparticles via in vivo bioorthogonal F-18 labeling.
Jeong HJ; Yoo RJ; Kim JK; Kim MH; Park SH; Kim H; Lim JW; Do SH; Lee KC; Lee YJ; Kim DW
Biomaterials; 2019 Apr; 199():32-39. PubMed ID: 30735894
[TBL] [Abstract][Full Text] [Related]
2. Mesoporous silica nanoparticle pretargeting for PET imaging based on a rapid bioorthogonal reaction in a living body.
Lee SB; Kim HL; Jeong HJ; Lim ST; Sohn MH; Kim DW
Angew Chem Int Ed Engl; 2013 Sep; 52(40):10549-52. PubMed ID: 23956036
[TBL] [Abstract][Full Text] [Related]
3. Bioorthogonal Radiolabeling of Azide-Modified Bacteria Using [
Alanizi AA; Sorlin AM; Parker MFL; López-Álvarez M; Qin H; Lee SH; Blecha J; Rosenberg OS; Engel J; Ohliger MA; Flavell RR; Wilson DM
Bioconjug Chem; 2024 Apr; 35(4):517-527. PubMed ID: 38482815
[No Abstract] [Full Text] [Related]
4. Radiolabeling Silica-Based Nanoparticles via Coordination Chemistry: Basic Principles, Strategies, and Applications.
Ni D; Jiang D; Ehlerding EB; Huang P; Cai W
Acc Chem Res; 2018 Mar; 51(3):778-788. PubMed ID: 29489335
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and biodistribution of multiple 89Zr-labeled pore-expanded mesoporous silica nanoparticles for PET.
Miller L; Winter G; Baur B; Witulla B; Solbach C; Reske S; Lindén M
Nanoscale; 2014 May; 6(9):4928-35. PubMed ID: 24675844
[TBL] [Abstract][Full Text] [Related]
6. Enhanced Tumor Diagnostic and Therapeutic Effect of Mesoporous Silica Nanoparticle-Mediated Pre-targeted Strategy.
Lv G; Li K; Qiu L; Peng Y; Zhao X; Li X; Liu Q; Wang S; Lin J
Pharm Res; 2018 Feb; 35(3):63. PubMed ID: 29450652
[TBL] [Abstract][Full Text] [Related]
7. Extra-Large Pore Mesoporous Silica Nanoparticles for Directing in Vivo M2 Macrophage Polarization by Delivering IL-4.
Kwon D; Cha BG; Cho Y; Min J; Park EB; Kang SJ; Kim J
Nano Lett; 2017 May; 17(5):2747-2756. PubMed ID: 28422506
[TBL] [Abstract][Full Text] [Related]
8. Lipid surface modifications increase mesoporous silica nanoparticle labeling properties in mesenchymal stem cells.
Rosenbrand R; Barata D; Sutthavas P; Mohren R; Cillero-Pastor B; Habibovic P; van Rijt S
Int J Nanomedicine; 2018; 13():7711-7725. PubMed ID: 30538454
[TBL] [Abstract][Full Text] [Related]
9. Identifying macrophage enrichment in atherosclerotic plaques by targeting dual-modal US imaging/MRI based on biodegradable Fe-doped hollow silica nanospheres conjugated with anti-CD68 antibody.
Ji R; Li X; Zhou C; Tian Q; Li C; Xia S; Wang R; Feng Y; Zhan W
Nanoscale; 2018 Nov; 10(43):20246-20255. PubMed ID: 30361722
[TBL] [Abstract][Full Text] [Related]
10. Nanoparticle PET-CT imaging of macrophages in inflammatory atherosclerosis.
Nahrendorf M; Zhang H; Hembrador S; Panizzi P; Sosnovik DE; Aikawa E; Libby P; Swirski FK; Weissleder R
Circulation; 2008 Jan; 117(3):379-87. PubMed ID: 18158358
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Integrity and Biological Fate of Chelator-Free Zirconium-89-Labeled Mesoporous Silica Nanoparticles.
Chen F; Goel S; Valdovinos HF; Luo H; Hernandez R; Barnhart TE; Cai W
ACS Nano; 2015 Aug; 9(8):7950-9. PubMed ID: 26213260
[TBL] [Abstract][Full Text] [Related]
12. Microwave-Synthesized Platinum-Embedded Mesoporous Silica Nanoparticles as Dual-Modality Contrast Agents: Computed Tomography and Optical Imaging.
Chu CH; Cheng SH; Chen NT; Liao WN; Lo LW
Int J Mol Sci; 2019 Mar; 20(7):. PubMed ID: 30925712
[TBL] [Abstract][Full Text] [Related]
13. F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging.
Kim HL; Sachin K; Jeong HJ; Choi W; Lee HS; Kim DW
ACS Med Chem Lett; 2015 Apr; 6(4):402-7. PubMed ID: 25893040
[TBL] [Abstract][Full Text] [Related]
14. CD80 Is Upregulated in a Mouse Model with Shear Stress-Induced Atherosclerosis and Allows for Evaluating CD80-Targeting PET Tracers.
Meletta R; Steier L; Borel N; Mu L; Keller C; Chiotellis A; Russo E; Halin C; Ametamey SM; Schibli R; Krämer SD; Müller Herde A
Mol Imaging Biol; 2017 Feb; 19(1):90-99. PubMed ID: 27430577
[TBL] [Abstract][Full Text] [Related]
15. F-18 labeling protocol of peptides based on chemically orthogonal strain-promoted cycloaddition under physiologically friendly reaction conditions.
Sachin K; Jadhav VH; Kim EM; Kim HL; Lee SB; Jeong HJ; Lim ST; Sohn MH; Kim DW
Bioconjug Chem; 2012 Aug; 23(8):1680-6. PubMed ID: 22770524
[TBL] [Abstract][Full Text] [Related]
16. Pretargeted PET Imaging Using a Bioorthogonal
Billaud EMF; Belderbos S; Cleeren F; Maes W; Van de Wouwer M; Koole M; Verbruggen A; Himmelreich U; Geukens N; Bormans G
Bioconjug Chem; 2017 Dec; 28(12):2915-2920. PubMed ID: 29191024
[TBL] [Abstract][Full Text] [Related]
17. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer.
Di Pasqua AJ; Yuan H; Chung Y; Kim JK; Huckle JE; Li C; Sadgrove M; Tran TH; Jay M; Lu X
J Nucl Med; 2013 Jan; 54(1):111-6. PubMed ID: 23100452
[TBL] [Abstract][Full Text] [Related]
18. [18F]azadibenzocyclooctyne ([18F]ADIBO): a biocompatible radioactive labeling synthon for peptides using catalyst free [3+2] cycloaddition.
Arumugam S; Chin J; Schirrmacher R; Popik VV; Kostikov AP
Bioorg Med Chem Lett; 2011 Dec; 21(23):6987-91. PubMed ID: 22024032
[TBL] [Abstract][Full Text] [Related]
19. Radiosynthesis and preclinical evaluation of 3'-Aza-2'-[(18)F]fluorofolic acid: a novel PET radiotracer for folate receptor targeting.
Betzel T; Müller C; Groehn V; Müller A; Reber J; Fischer CR; Krämer SD; Schibli R; Ametamey SM
Bioconjug Chem; 2013 Feb; 24(2):205-14. PubMed ID: 23273015
[TBL] [Abstract][Full Text] [Related]
20. In Vivo Tracking of the Degradation of Mesoporous Silica through
Bindini E; Ramirez MLA; Rios X; Cossío U; Simó C; Gomez-Vallejo V; Soler-Illia G; Llop J; Moya SE
Small; 2021 Jul; 17(30):e2101519. PubMed ID: 34145769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
